Infusion and persistent care administration firm Uptiv Well being introduced a partnership with the automation platform Lamar Well being to implement AI-powered automation for referral consumption and prior authorization processes.
Uptiv affords infusion remedy for sufferers with persistent circumstances by way of a hybrid mannequin that merges personalized in-clinic care with a digital platform.
Along with conventional infusion providers, Uptiv supplies care coordination, psychological well being teaching and different whole-person care providers.
Lamar Well being supplies an AI-powered automation platform aimed particularly at specialty remedy workflows.
The corporate was based by Stanford Medication, McKesson and CoverMyMeds, and it’s backed by Y Combinator and PennyJar Capital, Wholesome VC, Flex Capital, Dnipro VC and Shah Capital.
Lamar’s platform connects to main EHR methods and learns to enhance authorization processes.
The partnership goals to combine Lamar Well being’s specialty medication-focused AI platform into Uptiv Well being’s operations to streamline administrative workflows and scale back the time to therapy for sufferers with persistent circumstances.
Lamar Well being’s AI platform automates complicated administrative duties within the prior authorization course of, which the corporate says has usually been laborious and topic to delays.
The purpose is to reduce the authorization timeline and permit sufferers to start out therapy sooner, lower labor prices linked to consumption and prior authorization processes, redistribute employees time from paperwork to affected person interactions, improve the time from referral to therapy, and facilitate connecting with EHRs to take away pointless information entry and documentation.
“Our partnership with Lamar Well being permits us to allocate sources away from administrative burdens and towards creating distinctive affected person experiences that set us aside within the market,” Torben Nielsen, CEO of Uptiv Well being, stated in a press release.
THE LARGER TREND
In 2024, Uptiv Well being partnered with Lyn Well being to merge infusion remedy with persistent care administration by means of an providing dubbed Uptiv360. By means of the partnership, sufferers endure an onboarding course of by way of an app, adopted by an analysis by a nurse practitioner throughout an infusion go to.
Inside 48 hours, sufferers are related with a Lyn Well being care group to entry digital persistent care administration care, together with behavioral well being providers.
Additionally final yr, Uptiv Well being opened an infusion heart in Troy, Michigan.
The middle collaborates with referring physicians, hospital methods and payers to offer seamless and accessible look after infusion sufferers with persistent circumstances, together with a number of sclerosis, Crohn’s illness, colitis, rheumatoid arthritis, lupus, extreme bronchial asthma and allergy symptoms.
Uptiv launched in 2023 with $7.5 million in seed funding, alongside the opening of its flagship infusion heart in Westland, Michigan.
